Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine | Zendy

María Velasco | Zendy; ME Alfonso Galán | Zendy; María Luisa Maestro de las Casas | Zendy; Elia PérezFernández | Zendy; Diana Martínez-Ponce | Zendy; Beatriz González-Piñeiro | Zendy; Virgilio Castilla | Zendy; Carlos Guijarro | Zendy; Alejandro Algora Weber | Zendy; Juan Carlos Alonso Punter | Zendy; Gregorio Bonilla Zafra | Zendy; M. Mercedes Bueno Campaña | Zendy; Camilo Carrión Pulido | Zendy; Ana Isabel Díaz Cuasante | Zendy; Aurora Fabero Jiménez | Zendy; Rosa María Fariña García | Zendy; María Isabel González Anglada | Zendy; M. Mercedes Izquierdo Patron | Zendy; Susana Lorenzo | Zendy; Margarita Mosquera González | Zendy; Montserrat Pérez Encinas | Zendy; Francisco José Pérez Vega | Zendy; Renilla Sánchez | Zendy; María Esther | Zendy; Ma José Goyanes Galán | Zendy; Juan Emilio Losa | Zendy; Gil RodríguezCaravaca | Zendy

Open Access

Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

Author(s) -

María Velasco,

ME Alfonso Galán,

María Luisa Maestro de las Casas,

Elia PérezFernández,

Diana Martínez-Ponce,

Beatriz González-Piñeiro,

Virgilio Castilla,

Carlos Guijarro,

Alejandro Algora Weber,

Juan Carlos Alonso Punter,

Gregorio Bonilla Zafra,

M. Mercedes Bueno Campaña,

Camilo Carrión Pulido,

Ana Isabel Díaz Cuasante,

Aurora Fabero Jiménez,

Rosa María Fariña García,

María Isabel González Anglada,

M. Mercedes Izquierdo Patron,

Susana Lorenzo,

Margarita Mosquera González,

Montserrat Pérez Encinas,

Francisco José Pérez Vega,

Renilla Sánchez,

María Esther,

Ma José Goyanes Galán,

Juan Emilio Losa,

Gil RodríguezCaravaca

Publication year - 2021

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofab299

Subject(s) - medicine , covid-19 , immune system , coronavirus , virology , severe acute respiratory syndrome coronavirus , titer , respiratory system , immunology , antibody , disease , infectious disease (medical specialty) , outbreak

Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research